Abstract
The emergence of the COVID-19 pandemic has demonstrated the importance of face masks, making them a part of people’s routine during the pandemic which is still continuing. The face masks act as source control, reducing the transmission of infectious respiratory droplets by acting as a physical barrier blocking the droplets during speaking, breathing, coughing, sneezing, etc. The novelty of current study is to generate a spray with the droplet size distribution and velocity scale similar that of an actual cough or a mild sneeze to fundamentally investigate the effects of mask properties on model-cough impingement. The spray replicates the presence of both large-sized and small-sized droplets similar to an actual cough, which makes the observations relevant to real-life situations. The spray is impinged on different mask samples with varying properties like porosity, pore size, fabric thickness, and their combinations in multilayer configuration. The effect of mask properties on the droplet penetration volume is studied as it leads to the release of higher pathogen loading into the surroundings. A two-step penetration criteria based on viscous dissipation and capillary effects have been applied along with a third criteria based on the porosity of the mask sample that is specifically applicable for the spray impingement. The droplets present in the impinging cough can penetrate through the mask, atomizing into the aerosolization range and thus increasing the infection potential. Hence the effect of mask properties on the droplet size distribution as well as the velocity distribution of the penetrated droplets has been investigated using in-vitro experimental manikin model, which will be essential for estimating the range of infection spread. The filtration of virus-emulating nanoparticles as well as the fate of the penetrated respiratory droplets, with a susceptible person in the proximity, has also been investigated.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Some minor changes along with Reference citations and supplemental files were updated for clarity and consistency.
Data Availability
All data produced in the present work are contained in the manuscript
